Esperion Therapeutics
ESPR
#6830
Rank
HK$4.56 B
Marketcap
HK$19.10
Share price
-1.21%
Change (1 day)
63.80%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: HK$4.56 Billion

As of March 2026 Esperion Therapeutics has a market cap of HK$4.56 Billion. This makes Esperion Therapeutics the world's 6830th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$4.56 B-38.73%
2025HK$7.45 B113.67%
2024HK$3.48 B31.34%
2023HK$2.65 B-25.96%
2022HK$3.58 B51.06%
2021HK$2.37 B-54.55%
2020HK$5.22 B-59.1%
2019HK$12.77 B32.16%
2018HK$9.66 B-28.3%
2017HK$13.47 B515.44%
2016HK$2.18 B-43.63%
2015HK$3.88 B-39.12%
2014HK$6.38 B290.41%
2013HK$1.63 B

End of Day market cap according to different sources

On Mar 14th, 2026 the market cap of Esperion Therapeutics was reported to be:

HK$4.90 Billion
by Nasdaq info icon info icon
HK$4.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.182 T 25,810.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$617.09 B 13,416.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
HK$16.13 B 253.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$5.60 B 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$35.31 B 673.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$88.07 B 1,829.12%๐Ÿ‡บ๐Ÿ‡ธ USA